LeonaBio Inc
LONA
98 hedge funds and large institutions have $66.5M invested in LeonaBio Inc in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 34 increasing their positions, 17 reducing their positions, and 20 closing their positions.
885% more call options, than puts
Call options by funds: $2.5M | Put options by funds: $254K
100% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 17
0% more funds holding
Funds holding: 98 → 98 (0)
0% less ownership
Funds ownership: 5.87% → 5.87% (-0%)
0% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 20
2% less capital invested
Capital invested by funds: $68M → $66.5M (-$1.46M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$869K |
| 2 |
Two Sigma Advisers
New York
|
+$834K |
| 3 |
Renaissance Technologies
New York
|
+$811K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$764K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$757K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$1.45M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.41M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$671K |
| 4 |
JG
Jefferies Group
New York
|
-$614K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$605K |
LONA Hedge Fund Activity: Q3 2022 in Review
98 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q3 2022, worth a combined $66.5M — down 2.2% from $68M a quarter earlier.
Fund positioning in LONA was balanced in Q3 2022: 20 funds opened new positions, 20 closed out, 34 added to existing stakes and 17 trimmed.
The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $869K. The largest seller was Goldman Sachs, cutting an estimated $1.45M.
- 98 institutional investors held LeonaBio Inc (LONA) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $66.5M of LeonaBio Inc stock for Q3 2022, down 2.2% quarter-over-quarter.
- 20 funds opened new LeonaBio Inc positions in Q3 2022 and 20 closed out, a net change of 0 holders.
- The largest LeonaBio Inc buyer in Q3 2022 was Jacobs Levy Equity Management, an estimated $869K added.
- The largest LeonaBio Inc seller in Q3 2022 was Goldman Sachs, an estimated $1.45M sold.
Based on aggregated 13F filings for Q3 2022.